Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Intraday Session

 

Gainers

  • Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.6% to $1.35 during Friday's regular session. As of 12:30 EST, Dermata Therapeutics's stock is trading at a volume of 17.7 million, which is 7371.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.2 million.
  • Vaccinex (NASDAQ:VCNX) stock moved upwards by 22.43% to $1.91. Trading volume for Vaccinex's stock is 6.4 million as of 12:30 EST. This is 588.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $75.5 million.
  • Oak Street Health (NYSE:OSH) shares increased by 15.41% to $19.32. The current volume of 2.3 million shares is 80.9% of Oak Street Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $4.6 billion.
  • I-MAB (NASDAQ:IMAB) shares moved upwards by 13.98% to $26.17. Trading volume for I-MAB's stock is 430.5K as of 12:30 EST. This is 67.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 billion.
  • IsoPlexis (NASDAQ:ISO) stock increased by 12.86% to $7.37. As of 12:30 EST, this security is trading at a volume of 54.3K shares, making up 26.9% of its average full-day volume over the last 100 days. The company's market cap stands at $287.0 million.
  • Viking Therapeutics (NASDAQ:VKTX) stock moved upwards by 12.33% to $4.19. As of 12:30 EST, Viking Therapeutics's stock is trading at a volume of 875.0K, which is 90.6% of its average full-day volume over the last 100 days. The company's market cap stands at $327.8 million. As per the press release, Q4 earnings came out 2 days ago.

 

Losers

  • Adagio Therapeutics (NASDAQ:ADGI) shares fell 24.2% to $8.16 during Friday's regular session. Adagio Therapeutics's stock is trading at a volume of 7.4 million shares as of 12:30 EST. This is 87.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $907.8 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) shares fell 19.63% to $0.45. ENDRA Life Sciences's stock is trading at a volume of 1.0 million shares as of 12:30 EST. This is 324.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.9 million.
  • InnovAge Holding (NASDAQ:INNV) stock declined by 17.4% to $4.54. As of 12:30 EST, this security is trading at a volume of 662.1K shares, making up 81.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $614.5 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Seagen (NASDAQ:SGEN) shares decreased by 14.44% to $121.0. Trading volume for this security as of 12:30 EST is 5.1 million, which is 556.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.1 billion. As per the news, the Q4 earnings report came out 2 days ago.
  • Vera Therapeutics (NASDAQ:VERA) shares fell 10.19% to $17.11. As of 12:30 EST, this security is trading at a volume of 762.9K shares, making up 1088.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $364.0 million.
  • Integrity Applications (NASDAQ:IGAP) stock declined by 10.0% to $3.15. The company's market cap stands at $48.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.